Trophic hormones acutely stimulate steroid production by acting on the rate-determining step of steroidogenesis, the transport of the substrate, cholesterol, from intracellular stores to the inner mitochondrial membrane. There, cholesterol will be metabolished to pregnenolone. Using biochemical, morphological and molecular approaches, we demonstrated that the mitochondrial peripheral-type benzodiazepine receptor (PBR) mediates the transport of cholesterol from the outer to the inner mitochondrial membrane and the subsequent steroid biosynthesis. It is our hypothesis that PBR functions as a channel for cholesterol thus allowing this steroid precursor to get into the outer membrane and cross from the outer to the inner mitochondrial membrane through the intermembrane contact sites. Therefore, regulation of the expression of this PBR channel protein will control the amount of cholesterol available for testosterone synthesis and consequently testicular function and fertility. In the first aim, we will examine the structure/function relationship of the PBR receptor by deletion mutations and site-directed mutagenesis followed by reconstitution of the receptor in bacteria and PBR-negative R2C Leydig tumor cells, generated by PBR gene targeting. The information obtained, together with molecular modeling studies of PBR, will help define the structure of the receptor and its function as a channel for cholesterol, identify the ligand binding domains and the domains important for cholesterol uptake and transfer. In the second aim, we will examine the regulation of the expression of PBR by the endocrine disruptors, peroxisome proliferators (PPs), some of which are extensively used in humans and are shown to exert anti- androgenic activity and testicular atrophy in rodents. In preliminary studies, we observed that PPs, including hypolipidemic drugs and native and substituted long chain fatty acids, inhibit PBR expression and the hormone-stimulated Leydig cell steroidogenesis. These results will be confirmed and extended. Transcriptional suppression, mediated by the peroxisome proliferators-activated receptors transduction pathway, may be responsible for the biological effect of PPs on PBR expression. It is our goal to elucidate the mode of action and define the health hazard risk of hypolipidemic drugs and perfluorinated carboxylic acids PPs, putative suppressors of Leydig cell PBR, cholesterol transport, steroidogenesis, and testicular function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES007747-07
Application #
6382189
Study Section
Reproductive Biology Study Section (REB)
Program Officer
Heindel, Jerrold
Project Start
1995-04-01
Project End
2002-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
7
Fiscal Year
2001
Total Cost
$311,274
Indirect Cost
Name
Georgetown University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Wang, Hui-Jie; Fan, Jinjiang; Papadopoulos, Vassilios (2012) Translocator protein (Tspo) gene promoter-driven green fluorescent protein synthesis in transgenic mice: an in vivo model to study Tspo transcription. Cell Tissue Res 350:261-75
Batarseh, Amani; Barlow, Keith D; Martinez-Arguelles, Daniel B et al. (2012) Functional characterization of the human translocator protein (18kDa) gene promoter in human breast cancer cell lines. Biochim Biophys Acta 1819:38-56
Fan, Jinjiang; Papadopoulos, Vassilios (2012) Transcriptional regulation of translocator protein (Tspo) via a SINE B2-mediated natural antisense transcript in MA-10 Leydig cells. Biol Reprod 86:147, 1-15
Fan, J; Lindemann, P; Feuilloley, M G J et al. (2012) Structural and functional evolution of the translocator protein (18 kDa). Curr Mol Med 12:369-86
Campioli, Enrico; Batarseh, Amani; Li, Jiehan et al. (2011) The endocrine disruptor mono-(2-ethylhexyl) phthalate affects the differentiation of human liposarcoma cells (SW 872). PLoS One 6:e28750
Midzak, Andrew; Akula, Nagaraju; Lecanu, Laurent et al. (2011) Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis. J Biol Chem 286:9875-87
Castillo, Ana Fernanda; Fan, Jinjiang; Papadopoulos, Vassilios et al. (2011) Hormone-dependent expression of a steroidogenic acute regulatory protein natural antisense transcript in MA-10 mouse tumor Leydig cells. PLoS One 6:e22822
Midzak, Andrew; Rone, Malena; Aghazadeh, Yassaman et al. (2011) Mitochondrial protein import and the genesis of steroidogenic mitochondria. Mol Cell Endocrinol 336:70-9
Ostuni, Mariano A; Issop, Leeyah; PĂ©ranzi, Gabriel et al. (2010) Overexpression of translocator protein in inflammatory bowel disease: potential diagnostic and treatment value. Inflamm Bowel Dis 16:1476-87
Rupprecht, Rainer; Papadopoulos, Vassilios; Rammes, Gerhard et al. (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9:971-88

Showing the most recent 10 out of 55 publications